Literature DB >> 23335652

Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.

Giuseppe Scrascia1, Crescenzia Rotunno, Piero Guida, Manuela Conte, Lillà Amorese, Vito Margari, Luigi de Luca Tupputi Schinosa, Domenico Paparella.   

Abstract

OBJECTIVES: To compare coagulation and fibrinolysis activation in off-pump coronary artery bypass operation and in patients in whom a closed phosphorylcholine-coated cardiopulmonary bypass system was applied. Cardiopulmonary bypass induces activation of coagulative and fibrinolytic systems, which together with intraoperative haemodilution augment the risk of postoperative bleeding and transfusion of blood products.
METHODS: Thirty-six off-pump coronary artery bypass and 36 coronary artery bypass grafting patients in whom a closed, phosphorylcholine-coated cardiopulmonary bypass system with a closed-collapsible venous reservoir (Physio group) was used were prospectively enrolled. Activation of coagulation and fibrinolytic systems was assessed evaluating the release of prothrombin fragment 1.2 and plasmin-antiplasmin complex preoperatively (T0), 30 min after heparin administration (T1), 15 min after protamine administration (T2), 3 h after protamin administration (T3) and on postoperative days 1 (T4) and 5 (T5). Platelet function was evaluated through Platelet Function Analyzer 100(®).
RESULTS: During the operation, prothrombin fragment 1.2 and plasmin-antiplasmin levels were slightly higher in the Physio group, the difference being not statistically significant. In the off-pump coronary artery bypass group, prothrombin fragment 1.2 was significantly higher at T3 (618.7 ± 282.7 vs 416.6 ± 250.2 pmol/l; P = 0.006), T4 (416.7 ± 278.8 vs 310.2 ± 394.6 pmol/l; P < 0.001) and T5 (629.3 ± 295.2 vs 408.4 ± 409.7 pmol/l; P = 0.002), and plasmin-antiplasmin was significantly higher at T4 (731.1 ± 790 vs 334 ± 300.8 ng/ml; P = 0.019) and T5 (1744.4 ± 820.7 vs 860.1 ± 488.4 ng/ml; P = 0.003). Platelet Function Analyzer 100® closure time values were significantly higher in the Physio group patients at T3 (131.3 ± 105.7 vs 215.6 ± 58.9 s; P = 0.002). The off-pump coronary artery bypass patients had greater chest tube drainage (874.3 ± 371.5 vs 629.1 ± 334.5 ml; P = 0.005). The mean priming volume was 1240 ± 215 ml in the Physio group. Much more Physio patients received red blood cell transfusions (14 vs 25 patient; P = 0.009), because of higher intraoperative transfusion rates (6 vs 15 patients; P = 0.016). Despite similar preoperative haemoglobin levels (13 ± 1.2 vs 12.6 ± 1.4 g/dl; P = 0.2), postoperative haemoglobin levels were significantly lower in the Physio group.
CONCLUSIONS: The Physio cardiopulmonary bypass approach does not significantly alter haemostasis during the operation compared with off-pump coronary artery bypass providing a reduced activation in the postoperative period reducing also chest tube drainage. However, further priming volume reduction is required to decrease intraoperative red blood cell transfusion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335652      PMCID: PMC3630412          DOI: 10.1093/icvts/ivs525

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  24 in total

1.  Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study.

Authors:  R Ascione; S Williams; C T Lloyd; T Sundaramoorthi; A A Pitsis; G D Angelini
Journal:  J Thorac Cardiovasc Surg       Date:  2001-04       Impact factor: 5.209

2.  Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass.

Authors:  Bernard Lo; Rob Fijnheer; Domenico Castigliego; Cornelius Borst; Cor J Kalkman; Arno P Nierich
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

3.  Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation.

Authors:  Yves Fromes; Didier Gaillard; Olivier Ponzio; Maryline Chauffert; Marie-Françoise Gerhardt; Philippe Deleuze; Olivier M Bical
Journal:  Eur J Cardiothorac Surg       Date:  2002-10       Impact factor: 4.191

4.  Effect of blood transfusion on long-term survival after cardiac operation.

Authors:  Milo C Engoren; Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

5.  Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.

Authors:  M Ranucci; A Pazzaglia; G Isgrò; A Cazzaniga; A Ditta; A Boncilli; M Cotza; G Carboni; S Brozzi; C Bonifazi
Journal:  Int J Artif Organs       Date:  2002-09       Impact factor: 1.595

6.  A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial.

Authors:  Domenico Paparella; Giuseppe Scrascia; Crescenzia Rotunno; Nicola Marraudino; Pietro Guida; Micaela De Palo; Giovanni Rubino; Giangiuseppe Cappabianca
Journal:  J Cardiothorac Vasc Anesth       Date:  2012-05-30       Impact factor: 2.628

7.  A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit.

Authors:  George M Palatianos; Christophoros N Foroulis; Maria I Vassili; George Astras; Konstantinos Triantafillou; Emmanuel Papadakis; Angela A Lidoriki; Eugenia Iliopoulou; Efthimia N Melissari
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

Review 8.  Coagulation disorders of cardiopulmonary bypass: a review.

Authors:  Domenico Paparella; Stephanie J Brister; Michael R Buchanan
Journal:  Intensive Care Med       Date:  2004-07-24       Impact factor: 17.440

9.  Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.

Authors:  J D Puskas; W H Williams; P G Duke; J R Staples; K E Glas; J J Marshall; M Leimbach; P Huber; S Garas; B H Sammons; S A McCall; R J Petersen; D E Bailey; H Chu; E M Mahoney; W S Weintraub; R A Guyton
Journal:  J Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 5.209

10.  Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery.

Authors:  B D Spiess; C Vocelka; R P Cochran; L Soltow; W L Chandler
Journal:  J Cardiothorac Vasc Anesth       Date:  1998-06       Impact factor: 2.628

View more
  2 in total

1.  eComment. Is retrograde autologous priming effective on cerebral functions and haematocrit levels?

Authors:  Hasan Alper Gurbuz; Ahmet Baris Durukan; Murat Tavlasoglu; Cem Yorgancioglu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06

Review 2.  Development and Application of 3D Bioprinted Scaffolds Supporting Induced Pluripotent Stem Cells.

Authors:  Dezhi Lu; Yang Liu; Wentao Li; Hongshi Ma; Tao Li; Xiaojun Ma; Yuanqing Mao; Qianqian Liang; Zhenjiang Ma; Jinwu Wang
Journal:  Biomed Res Int       Date:  2021-09-13       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.